Please use this identifier to cite or link to this item:
https://observatorio.fm.usp.br/handle/OPI/21932
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor | Sistema FMUSP-HC: Faculdade de Medicina da Universidade de São Paulo (FMUSP) e Hospital das Clínicas da FMUSP | - |
dc.contributor.author | NETO, Adalberto Studart | - |
dc.contributor.author | NETO, Herval R. Soares | - |
dc.contributor.author | SIMABUKURO, Mateus M. | - |
dc.contributor.author | SOLLA, Davi J. F. | - |
dc.contributor.author | GONCALVES, Marcia R. R. | - |
dc.contributor.author | FORTINI, Ida | - |
dc.contributor.author | CASTRO, Luiz H. M. | - |
dc.contributor.author | NITRINI, Ricardo | - |
dc.date.accessioned | 2017-10-24T13:18:50Z | - |
dc.date.available | 2017-10-24T13:18:50Z | - |
dc.date.issued | 2017 | - |
dc.identifier.citation | ALZHEIMER DISEASE & ASSOCIATED DISORDERS, v.31, n.3, p.239-243, 2017 | - |
dc.identifier.issn | 0893-0341 | - |
dc.identifier.uri | https://observatorio.fm.usp.br/handle/OPI/21932 | - |
dc.description.abstract | Background: Rapidly progressive dementia (RPD) is usually associated with Creutzfeldt-Jakob disease, a fatal condition. Current advances in the understanding of immune-mediated diseases allow the diagnosis of previously unrecognized treatable RPDs. Objective of the Study: The objective of the study was to describe the prevalence and causes of RPD in a neurology service, identifying potentially reversible causes. Methods: We carried out a cross-sectional evaluation of all patients admitted to the neurology unit of a tertiary hospital in Brazil between March 2012 and February 2015. We included patients who had progressed to moderate or severe dementia within a few months or up to 2 years at the time of hospitalization, and used multivariable logistic regression analysis to identify factors associated with a favorable outcome. Results: We identified 61 RPD (3.7%) cases among 1648 inpatients. Mean RPD patients' age was 48 years, and median time to progression was 6.4 months. Immune-mediated diseases represented the most commonly observed disease group in this series (45.9% of cases). Creutzfeldt-Jakob disease (11.5%) and nonprion neurodegenerative diseases (8.2%) were less common in this series. Outcome was favorable in 36/61 (59.0%) RPD cases and in 28/31 (89.3%) of immune-mediated cases. Favorable outcome was associated with shorter time from symptom onset to diagnosis and abnormal cerebrospinal fluid findings. Conclusions: Immune-mediated diseases were the most common cause of RPD in this series. Timely evaluation and diagnosis along with institution of appropriate therapy are required in RPD, especially in view of potentially reversible causes. | - |
dc.language.iso | eng | - |
dc.publisher | LIPPINCOTT WILLIAMS & WILKINS | - |
dc.relation.ispartof | Alzheimer Disease & Associated Disorders | - |
dc.rights | restrictedAccess | - |
dc.subject | rapidly progressive dementia | - |
dc.subject | prion diseases | - |
dc.subject | Creutzfeldt-Jakob disease | - |
dc.subject | immune-mediated encephalopathies | - |
dc.subject.other | creutzfeldt-jakob-disease | - |
dc.subject.other | alzheimers-disease | - |
dc.subject.other | referral-center | - |
dc.subject.other | onset dementia | - |
dc.subject.other | diagnosis | - |
dc.subject.other | pathogenesis | - |
dc.subject.other | guidelines | - |
dc.subject.other | athens | - |
dc.title | Rapidly Progressive Dementia: Prevalence and Causes in a Neurologic Unit of a Tertiary Hospital in Brazil | - |
dc.type | article | - |
dc.rights.holder | Copyright LIPPINCOTT WILLIAMS & WILKINS | - |
dc.identifier.pmid | 27849640 | - |
dc.subject.wos | Clinical Neurology | - |
dc.subject.wos | Pathology | - |
dc.type.category | original article | - |
dc.type.version | publishedVersion | - |
hcfmusp.description.beginpage | 239 | - |
hcfmusp.description.endpage | 243 | - |
hcfmusp.description.issue | 3 | - |
hcfmusp.description.volume | 31 | - |
hcfmusp.origem | WOS | - |
hcfmusp.origem.id | 2-s2.0-84995376688 | - |
hcfmusp.origem.id | WOS:000408516100009 | - |
hcfmusp.publisher.city | PHILADELPHIA | - |
hcfmusp.publisher.country | USA | - |
hcfmusp.relation.reference | Appleby BS, 2011, EXPERT OPIN PHARMACO, V12, P1, DOI 10.1517/14656566.2010.514903 | - |
hcfmusp.relation.reference | Bien CG, 2012, BRAIN, V135, P1622, DOI 10.1093/brain/aws082 | - |
hcfmusp.relation.reference | BROWN P, 1994, ANN NEUROL, V35, P513, DOI 10.1002/ana.410350504 | - |
hcfmusp.relation.reference | Chitravas N, 2011, ANN NEUROL, V70, P437, DOI 10.1002/ana.22454 | - |
hcfmusp.relation.reference | Eurelings LSM, 2010, J NEUROL SCI, V295, P131, DOI 10.1016/j.jns.2010.04.020 | - |
hcfmusp.relation.reference | Fermo O.P., 2014, NEUROL CLIN PRACT, V4, P493 | - |
hcfmusp.relation.reference | Geschwind MD, 2008, ANN NEUROL, V64, P97, DOI 10.1002/ana.21430 | - |
hcfmusp.relation.reference | Geschwind MD, 2007, NEUROL CLIN, V25, P783, DOI 10.1016/j.ncl.2007.04.001 | - |
hcfmusp.relation.reference | Geschwind Michael D, 2010, Continuum (Minneap Minn), V16, P31, DOI 10.1212/01.CON.0000368211.79211.4c | - |
hcfmusp.relation.reference | Hoftberger R, 2015, CURR OPIN ONCOL, V27, P489, DOI 10.1097/CCO.0000000000000222 | - |
hcfmusp.relation.reference | Huang N, 2003, NEUROLOGY, V61, P354 | - |
hcfmusp.relation.reference | Josephs KA, 2009, ARCH NEUROL-CHICAGO, V66, P201, DOI 10.1001/archneurol.2008.534 | - |
hcfmusp.relation.reference | Kelley BJ, 2009, COGN BEHAV NEUROL, V22, P22, DOI 10.1097/WNN.0b013e318192cc8d | - |
hcfmusp.relation.reference | Lancaster E, 2012, NAT REV NEUROL, V8, P380, DOI 10.1038/nrneurol.2012.99 | - |
hcfmusp.relation.reference | McKeon Andrew, 2010, Continuum (Minneap Minn), V16, P80, DOI 10.1212/01.CON.0000368213.63964.34 | - |
hcfmusp.relation.reference | McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005 | - |
hcfmusp.relation.reference | O'Toole O, 2013, SEMIN NEUROL, V33, P357, DOI 10.1055/s-0033-1359318 | - |
hcfmusp.relation.reference | Papageorgiou SG, 2009, ALZ DIS ASSOC DIS, V23, P347, DOI 10.1097/WAD.0b013e31819e6b28 | - |
hcfmusp.relation.reference | Papageorgiou SG, 2009, ALZ DIS ASSOC DIS, V23, P337, DOI 10.1097/WAD.0b013e31819e099b | - |
hcfmusp.relation.reference | Paterson RW, 2012, ARCH NEUROL-CHICAGO, V69, P1578, DOI 10.1001/2013.jamaneurol.79 | - |
hcfmusp.relation.reference | Paterson RW, 2012, NEUROL CLIN PRACT, V2, P187 | - |
hcfmusp.relation.reference | Poser S, 1999, BRAIN, V122, P2345, DOI 10.1093/brain/122.12.2345 | - |
hcfmusp.relation.reference | Rosenbloom MH, 2009, CURR NEUROL NEUROSCI, V9, P359, DOI 10.1007/s11910-009-0053-2 | - |
hcfmusp.relation.reference | Rosenbloom MH, 2011, NEUROLOGIST, V17, P67, DOI 10.1097/NRL.0b013e31820ba5e3 | - |
hcfmusp.relation.reference | Sala I, 2012, ALZ DIS ASSOC DIS, V26, P267, DOI 10.1097/WAD.0b013e3182368ed4 | - |
hcfmusp.relation.reference | Schmidt C, 2011, ARCH NEUROL-CHICAGO, V68, P1124, DOI 10.1001/archneurol.2011.189 | - |
hcfmusp.relation.reference | Shields J, 2010, J NEUROPATH EXP NEUR, V69, P533 | - |
hcfmusp.relation.reference | Titulaer MJ, 2013, LANCET NEUROL, V12, P157, DOI 10.1016/S1474-4422(12)70310-1 | - |
hcfmusp.relation.reference | Tschampa HJ, 2001, J NEUROL NEUROSUR PS, V71, P33, DOI 10.1136/jnnp.71.1.33 | - |
hcfmusp.relation.reference | Vitali P, 2011, NEUROLOGY, V76, P1711, DOI 10.1212/WNL.0b013e31821a4439 | - |
hcfmusp.relation.reference | World Health Organization, 1998, GLOB SURV DIAGN THER, P9 | - |
hcfmusp.relation.reference | WILL RG, 1984, J NEUROL NEUROSUR PS, V47, P134, DOI 10.1136/jnnp.47.2.134 | - |
hcfmusp.relation.reference | Zuliani L, 2012, J NEUROL NEUROSUR PS, V83, P638, DOI 10.1136/jnnp-2011-301237 | - |
dc.description.index | MEDLINE | - |
hcfmusp.citation.scopus | 24 | - |
hcfmusp.scopus.lastupdate | 2024-03-29 | - |
Appears in Collections: | Artigos e Materiais de Revistas Científicas - FM/MNE Artigos e Materiais de Revistas Científicas - HC/ICHC Artigos e Materiais de Revistas Científicas - LIM/15 Artigos e Materiais de Revistas Científicas - LIM/45 Artigos e Materiais de Revistas Científicas - ODS/03 |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
art_NETO_Rapidly_Progressive_Dementia_Prevalence_and_Causes_in_a_2017.PDF Restricted Access | publishedVersion (English) | 122.83 kB | Adobe PDF | View/Open Request a copy |
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.